跳出常规:肾移植中的新型肾脏保护策略
本文为综述,聚焦肾移植中非免疫学因素的肾脏保护策略。作者指出,尽管急性排斥反应发生率下降,长期移植物存活改善有限,多数移植物丢失有可识别原因,而非特发性纤维化/萎缩或钙调神经磷酸酶抑制剂肾毒性。文中讨论高血压及其治疗药物、降脂、钠水摄入、高尿酸血症、代谢性酸中毒及钠-葡萄糖协同转运蛋白2抑制剂对长期移植肾健康的作用。
要点
- 肾移植长期存活改善有限,非免疫学损伤是潜在干预靶点
- 借鉴原生肾病有效的非免疫策略或可惠及移植肾
- 关注血压、血脂、尿酸、酸碱及SGLT2抑制剂等环节
核心结论
- 减轻非免疫学损伤的策略可能为肾移植带来获益,值得作为免疫抑制方案的辅助。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 急性排斥反应发生率虽下降,长期移植物存活仅有限改善。
- 多数移植肾丢失有可识别原因,而非特发性纤维化/萎缩或钙调神经磷酸酶抑制剂肾毒性。
- 免疫学与非免疫学因素共同导致移植物纤维化的共同通路。
临床怎么用
- 在管理良好的免疫抑制方案基础上,可考虑针对血压、血脂、钠水摄入、尿酸、代谢性酸中毒及SGLT2抑制剂使用等非免疫学环节进行辅助管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the reduction in the incidence of acute rejection, a major risk factor for graft loss, there has been only modest improvement in long-term graft survival. Most cases of kidney graft loss have an identifiable cause that is not idiopathic fibrosis/atrophy or calcineurin inhibitor nephrotoxicity. Distinct immunologic and nonimmunologic factors conspire to lead to a common pathway of allograft fibrosis. It remains plausible that mitigating nonimmunologic damage using strategies proven effective in native kidney disease may yield benefit in kidney transplantation. In this review, we will focus on nonimmunologic aspects of kidney transplant care that may prove to be valuable adjuncts to a well-managed immunosuppression regimen. Topics to be addressed include the roles of hypertension and agents used to treat it, lipid lowering, sodium and water intake, elevated uric acid, metabolic acidosis, and the use of sodium-glucose cotransporter 2 inhibitors on long-term kidney transplant health.
引用
- Ibrahim HN, Murad DN, Knoll GA, et al. Thinking Outside the Box: Novel Kidney Protective Strategies in Kidney Transplantation. Clin J Am Soc Nephrol. 2021. PMID: 33757985. doi:10.2215/CJN.15070920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。